John Paul Johnson - Mar 2, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 2, 2022
Transactions value $
-$1,139,165
Form type
4
Date filed
3/4/2022, 07:59 PM
Previous filing
Mar 3, 2022
Next filing
Aug 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $0 +71.7K +45.85% $0.00 228K Mar 2, 2022 Direct F1, F2
transaction EVH Class A Common Stock Tax liability -$248K -9.02K -3.95% $27.54 219K Mar 2, 2022 Direct F2, F3
transaction EVH Class A Common Stock Tax liability -$891K -32.3K -14.76% $27.54 187K Mar 3, 2022 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Leveraged Restricted Stock Unit Options Exercise $0 -71.7K -100% $0.00* 0 Mar 2, 2022 Class A Common Stock 71.7K $0.00 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of the leveraged stock units granted to Mr. Johnson on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units.
F5 Leveraged Stock Units vested on March 2, 2022.
F6 The Leveraged Stock Units do not expire.